Attending the Launch of Tommy’s National Centre for Preterm Birth Research
It was wonderful for members of our team to celebrate Tommy’s launch of their amazing new preterm birth centre. Always energising and inspiring to be in a room full of clinicians, researchers, midwives, engineers, supporters, and those with lived experience – for such an important cause. We are excited about how impactful our Callavid device will …
Making the 2023 List of 200 Trailblazing Leaders in Women’s Health and FemTech
Congrats to our co-founders Dr. Lara Zibners and Thang Vo-Ta on being named in the annual 200 Trailblazing Leaders in Women’s Health and FemTech. It’s a real who’s who of the influential leaders working to improve the access and quality of healthcare for women worldwide. We’re delighted for the recognition of Lara, Thang and of …
Attending the LSX Investival Showcase
It was a busy start to kick-off Europe’s biggest dedicated healthcare investment week by taking part in the LSX – partnering for Life Science eXecutives Investival Showcase here in London. Always a privilege to be able to share Calla Lily Clinical Care‘s exciting progress with our drug delivery technology and to meet with several new …
Wall Street Journal coverage
Am grateful to Katie Deighton of The Wall Street Journal for her interview about the challenges we faced commercialising a completely new & innovative period care product, and our pivot to the medical devices (drug delivery) space. Understandably there hasn’t been anywhere near the press interest we had when things looked incredibly promising, to focus …
Attending the Decoding The Future of Women Summit
It was an exciting start to London Tech Week 2023 by taking part in FemTech Lab’s Decoding The Future of Women Summit. Always a privilege to be able to share Calla Lily Clinical Care’s exciting progress with our technology and to discuss trends & observations about the future of femtech with such an esteemed panel.